These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
705 related articles for article (PubMed ID: 11569737)
21. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Nazerian K; Witter RL; Lee LF; Yanagida N Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888 [TBL] [Abstract][Full Text] [Related]
22. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses. Buscaglia C; Nervi P; Risso M Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986 [TBL] [Abstract][Full Text] [Related]
23. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox. Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of Factors Influencing Efficacy of Vaccine Strain CVI988 Against Marek's Disease in Meat-Type Chickens. Gimeno IM; Cortes AL; Faiz NM; Barbosa T; Villalobos T Avian Dis; 2015 Sep; 59(3):400-9. PubMed ID: 26478159 [TBL] [Abstract][Full Text] [Related]
25. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988. Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens. Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611 [TBL] [Abstract][Full Text] [Related]
27. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Baigent SJ; Smith LP; Currie RJ; Nair VK Avian Pathol; 2007 Dec; 36(6):467-74. PubMed ID: 17994325 [TBL] [Abstract][Full Text] [Related]
28. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity. Witter RL; Bacon LD; Calvert JG Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514 [TBL] [Abstract][Full Text] [Related]
29. Antibody titers to infectious bursal disease virus in broiler chicks after vaccination at one day of age with infectious bursal disease virus and Marek's disease virus. Knoblich HV; Sommer SE; Jackwood DJ Avian Dis; 2000; 44(4):874-84. PubMed ID: 11195642 [TBL] [Abstract][Full Text] [Related]
30. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine. Sharma JM Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603 [TBL] [Abstract][Full Text] [Related]
32. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus. Karpathy RC; Firth GA; Tannock GA Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882 [TBL] [Abstract][Full Text] [Related]
33. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines. Bacon LD; Witter RL Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902 [TBL] [Abstract][Full Text] [Related]
34. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat. Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614 [TBL] [Abstract][Full Text] [Related]
35. Protective immunity to infectious bronchitis in broilers vaccinated against Marek's disease either in ovo or at hatch and against infectious bronchitis at hatch. Avakian AP; Wakenell PS; Grosse D; Whitfill CE; Link D Avian Dis; 2000; 44(3):536-44. PubMed ID: 11007000 [TBL] [Abstract][Full Text] [Related]
36. Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens. Debba-Pavard M; Ait-Lounis A; Soubieux D; Rasschaert D; Dambrine G Vaccine; 2008 Sep; 26(38):4904-12. PubMed ID: 18680776 [TBL] [Abstract][Full Text] [Related]
37. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression. Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594 [TBL] [Abstract][Full Text] [Related]
38. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus. Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630 [TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens. Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987 [TBL] [Abstract][Full Text] [Related]
40. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains. de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]